Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

TEMPI Syndrome

A rare syndrome characterized by telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The TEMPI Syndrome.
The TEMPI syndrome is a rare and acquired disorder characterized by five salient features: (1) telangiectasias, (2) elevated… 
2018
2018
Complete Responses in the TEMPI Syndrome after Treatment with Daratumumab.
Daratumumab in the TEMPI Syndrome Patients with the TEMPI syndrome often have a response to bortezomib or autologous… 
  • figure 1
Review
2018
Review
2018
TEMPI Syndrome: Erythrocytosis in Plasma Cell Dyscrasia
&NA; TEMPI (telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections… 
  • table 1
  • table 2
Review
2015
Review
2015
Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist
TEMPI syndrome (telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid… 
  • table 1
  • table 2
  • figure 1
  • table 3
2015
2015
Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation
Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation 
  • figure 1
  • table 1
  • table 1
2015
2015
Difficulties in hematopoietic progenitor cell collection from a patient with TEMPI syndrome and severe iatrogenic iron deficiency
Collection of hematopoietic progenitor cells by apheresis (HPC‐A) requires separation of cells by density. Previous studies… 
2012
2012
Complete and partial responses of the TEMPI syndrome to bortezomib.
Additional cases are reported in which bortezomib reverses many of the manifestations of the TEMPI syndrome. 
  • figure 1
2012
2012
Bortezomib to treat the TEMPI syndrome.
Telangiectasias, erythrocytosis, monoclonal gammopathy, perinephric-fluid collection, and intrapulmonary shunting are… 
  • figure 1
  • table 1
2012
2012
A new case of TEMPI syndrome
We present an interesting case of a woman with new onset hypertension and abdominal fullness who was found to have huge bilateral… 
  • figure 1
  • figure 2
Review
2011
Review
2011
The TEMPI syndrome--a novel multisystem disease.
To the Editor: The description of a man with erythrocytosis and perinephric fluid collections recently appeared in the Case… 
  • figure 1
  • table 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE